Summary & Overview
HCPCS G9833: Patient Transfer to Practice After Initiation of Chemotherapy
HCPCS Level II code G9833 represents the transfer of a patient to a practice after chemotherapy has already been initiated. This code captures the administrative and clinical activities associated with assuming care of a patient mid-course of systemic cancer therapy, and is relevant for billing continuity and care coordination in oncology practices nationwide. Nationally, a standardized approach to documenting transfers affects practice workflows, claims processing, and care transitions for patients receiving complex treatment regimens.
Key payers in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of the clinical context for use of G9833, typical service settings, and payer coverage considerations. The publication outlines benchmarks for billing utilization where available, summarizes relevant policy and coding guidance updates, and situates the code within oncology care pathways to clarify appropriate use.
This summary is intended to inform revenue cycle staff, oncology clinicians, and policy analysts about the role of G9833 in documenting care transitions after chemotherapy initiation, expected sites of service, and the payer landscape affecting reimbursement and claims adjudication at a national level.
Billing Code Overview
HCPCS Level II code G9833 denotes patient transfer to practice after initiation of chemotherapy. This service represents the administrative and clinical transition when a patient who has begun chemotherapy elsewhere is transferred into a treating practice for ongoing management.
-
Service type: Continuity of oncology care following chemotherapy initiation
-
Typical site of service: Ambulatory oncology clinic or physician practice setting
Clinical & Coding Specifications
Clinical Context
A patient diagnosed with a malignancy has had chemotherapy initiated at an external oncology infusion center and is being transferred to a new oncology practice for ongoing systemic therapy and follow-up. Typical patients are adults receiving IV cytotoxic or targeted agents who require continuity of care, review of prior treatment, verification of recent dosing, and coordination of future infusions. The receiving practice reviews prior chemo orders, verifies infusion tolerability and adverse effects, performs medication reconciliation, assesses performance status and labs, documents cancer staging and treatment intent, and schedules subsequent chemotherapy visits and supportive care (antiemetics, growth factors, transfusions) as appropriate. This transfer visit includes communication with the referring provider, review of prior administration records, and establishment of the new practice as the primary site for ongoing chemotherapy administration. Typical site of service: outpatient oncology clinic/infusion center. Service type: care coordination and transfer-of-care visit associated with active chemotherapy management.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when work required to manage the transfer (complex documentation, extended coordination) substantially increases the usual service work. |